ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $4,000 | -66.7% | 79 | -68.4% | 0.00% | -100.0% |
| Q2 2022 | $12,000 | -7.7% | 250 | +42.0% | 0.00% | 0.0% |
| Q1 2022 | $13,000 | -18.8% | 176 | -15.4% | 0.00% | 0.0% |
| Q4 2021 | $16,000 | +23.1% | 208 | -12.2% | 0.00% | 0.0% |
| Q3 2021 | $13,000 | -18.8% | 237 | -35.1% | 0.00% | -50.0% |
| Q2 2021 | $16,000 | 0.0% | 365 | +14.1% | 0.00% | 0.0% |
| Q1 2021 | $16,000 | +77.8% | 320 | +42.9% | 0.00% | +100.0% |
| Q4 2020 | $9,000 | +200.0% | 224 | +286.2% | 0.00% | 0.0% |
| Q3 2020 | $3,000 | 0.0% | 58 | +3.6% | 0.00% | 0.0% |
| Q2 2020 | $3,000 | 0.0% | 56 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $3,000 | – | 56 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |